Inactive conformation of an insulin despite its wild‐type sequence

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Protein Science

• Publication date

  1997-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/PRO.5560060307PMID 9070440PMCID PMC2143665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal Structure of 6,7-Dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione

  2019cited by this paper
• Single chain des-(B30) insulin. Intramolecular crosslinking of insulin by trypsin catalyzed transpeptidation.

  2009cited by this paper
• Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.

  2009cited by this paper
• Intramolecular cross-linking of insulin. Preparation and properties of oxalyl- and malonyl-bis(methionyl) insulin.

  2009cited by this paper
• The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.

  2009cited by this paper
• Extensive modification of protein amino groups by reductive addition of different sized substituents.

  2009cited by this paper
• Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.

  2009cited by this paper
• Comparative studies on the dynamics of crosslinked insulin

  2005cited by this paper
• NMR View: A computer program for the visualization and analysis of NMR data

  1994cited by this paper
• Receptor binding redefined by a structural switch in a mutant human insulin

  1994cited by this paper
• Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor.

  1994cited by this paper
• An insulin with the native sequence but virtually no activity.

  1994cited by this paper
• High-resolution structure of an engineered biologically potent insulin monomer, B16 Tyr-->His, as determined by nuclear magnetic resonance spectroscopy.

  1994cited by this paper
• Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus.

  1993cited by this paper
• Structure and evolution of insulins: Implications for receptor binding

  1992cited by this paper
• The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy.

  1992cited by this paper
• Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.

  1992cited by this paper
• Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition.

  1992cited by this paper
• The conformational stability and flexibility of insulin with an additional intramolecular cross-link.

  1991cited by this paper
• Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition.

  1991cited by this paper
• Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions.

  1991cited by this paper
• C-C-A-G-G-C-m5C-T-G-G. Helical fine structure, hydration, and comparison with C-C-A-G-G-C-C-T-G-G.

  1991cited by this paper
• X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue.

  1991cited by this paper
• Toward the solution structure of human insulin: sequential 2D 1H NMR assignment of a des-pentapeptide analogue and comparison with crystal structure.

  1990cited by this paper
• A New Maximum Entropy Processing Algorithm, with Applications to Nuclear Magnetic Resonance Experiments

  1989cited by this paper
• Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.

  1989cited by this paper
• Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation.

  1989cited by this paper
• Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29.

  1989cited by this paper
• Molecular dynamics simulation techniques for determination of molecular structures from nuclear magnetic resonance data.

  1989cited by this paper
• The structure of 2Zn pig insulin crystals at 1.5 A resolution.

  1988cited by this paper
• Protein structures from NMR.

  1988cited by this paper
• Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain.

  1987cited by this paper
• REFINEMENT OF THE STRUCTURE OF DESPENTAPEPTIDE (B26—30) INSULIN AT 1.5 RESOLUTION

  1987cited by this paper
• Shortened insulin with enhanced in vitro potency.

  1987cited by this paper
• Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.

  1986cited by this paper
• A shortened insulin with full in vitro potency.

  1985cited by this paper
• Insulin's structure as a modified and monomeric molecule

  1984cited by this paper
• Molecular dynamics with coupling to an external bath

  1984cited by this paper
• The theory and practice of distance geometry

  1983cited by this paper
• Evidence concerning insulin activity from the structure of a cross-linked derivative.

  1981cited by this paper
• Crystal Structure, Aggregation and Biological Potency of Beef Insulin Cross-Linked at A1 and B29 by Diaminosuberic Acid

  1980cited by this paper
• Stable calculation of coordinates from distance information

  1978cited by this paper
• Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine

  1976cited by this paper
• Receptor-binding region of insulin

  1976cited by this paper
• B-chain shortening of matrix-bound insulin with pepsin, II. Preparation and properties of camel des-pentapeptide (B26-30)- and des-PheB1-des-pentapeptide (B26-30)- insulin.

  1975cited by this paper
• [B-chain shortening of matrix-bound insulin by pepsin, I:Preparation and properties of bovine des-pentapeptide(B26-30) insulin (suthor's transl)].

  1975cited by this paper
• The relation of conformation and association of insulin to receptor binding; x-ray and circular-dichroism studies on bovine and hystricomorph insulins.

  1975cited by this paper
• B-Kettenverkürzung von polymergebundenem Insulin mit Pepsin, I. Darstellung und Eigenschaften von Des-Pentapeptid (B26-30)-Rinderinsulin

  1975cited by this paper
• Receptor-binding assay of chemically modified insulins

  1974cited by this paper
• The biological activity and the binding affinity of modified insulins determined on isolated rat fat cells

  1974cited by this paper
• Reduction/reoxidation studies with cross-linked insulin derivatives.

  1974cited by this paper
• NalphaA1-N-epsilon B-29-crosslinked diaminosuberoylinsulin, a potential intermediate for the chemical synthesis of insulin.

  1973cited by this paper
• The effect of a non-peptide interchain crosslink on the reoxidation of reduced insulin.

  1973cited by this paper
• Intramolecular cross‐linked insulin

  1972cited by this paper
• Preparation of N A1 ,N B29 -adipoylinsulin, an intramolecularly crosslinked derivative of beef insulin.

  1972cited by this paper

• Structural and Functional Study of the GlnB22-Insulin Mutant Responsible for Maturity-Onset Diabetes of the Young

  2014influential citation
• Insulin: a small protein with a long journey

  2010cites this paper
• Insulin - structure, function, design

  2009cites this paper
• The solution structure of a superpotent b‐chain‐shortened single‐replacement insulin analogue

  2008cites this paper
• Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.

  2005cites this paper
• Backbone-Backbone H-Bonds Make Context-Dependent Contributions to Protein Folding Kinetics and Thermodynamics: Lessons from Amide-to-Ester Mutations.

  2005cites this paper
• Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.

  2004cites this paper
• Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.

  2004cites this paper
• Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.

  2004cites this paper
• The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes

  2003cites this paper
• Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.

  2002cites this paper
• Insulin & Related Proteins - Structure to Function and Pharmacology

  2002cites this paper
• A cavity‐forming mutation in insulin induces segmental unfolding of a surrounding α‐helix

  2002cites this paper
• A cavity-forming mutation in insulin induces segmental unfolding of a surrounding alpha-helix.

  2002cites this paper
• Insulin at the German Wool Research Institute-Retrospect and Outlook

  2002cites this paper
• Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.

  2002cites this paper
• Peptide backbone chemistry and membrane channel function: effects of a single amide-to-ester replacement on gramicidin channel structure and function.

  2001cites this paper
• Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.

  2000cites this paper
• Conformational correlation and coupled motion between residue A21 and B25 side chain observed in crystal structures of insulin mutants at position A21.

  2000cites this paper
• A structural switch in a mutant insulin exposes key residues for receptor binding.

  1998cites this paper